Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn: Hot funding market for startups forecast

Startups seeking funding can cash in right now from a market flush with capital and seeking promising ventures, a panel of UConn experts said recently....

| By Kelley Gipson

New! Corporate Professional Development Courses

The Governors Workforce Council’s (GWC) strategic plan includes the bioscience industry. Several initiatives are underway to create more talent to meet the demand of our...

| By Kelley Gipson

BI announces progress re lung cancer, obseity

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have announced the extension and expansion of their joint Virtual Research and Development Center (VRDC)...

| By Kelley Gipson

BMS drug helps lung cancer patients

A drug that helps the immune system fight cancer gave dramatic results when used with chemotherapy before surgery in patients with operable lung tumors, doctors...

| By Kelley Gipson

Lumeda reports $5.3M series A financing

Lumeda reports the closing of a series A financing. The round was led by Connecticut Innovations, with participation from Cycle Venture Partners, and brings the total...

| By Kelley Gipson

CT Innovations considering $200M for startups

Following its move to New Haven, CT Innovations (CI) is pursuing an ambitious five-year plan to invest $200M in startups. Forbes has singled out CI...

| By Kelley Gipson

Yale scientists advance brain tumor detection

Researchers at Yale University report development of a new sodium magnetic resonance spectroscopic imaging, or MRSI, method that will help detect gliomas, a type of brain...

| By Kelley Gipson

Pfizer begins human testing on new COVID pill

Pfizer is looking to follow up on its successful COVID-19 vaccine with a pill that people could take when they’re first infected to prevent a severe...